FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder ...Middle East

Lumasiran (Oxlumo) is the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder that causes recurrent kidney stones and loss of kidney function. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder )

Also on site :

• Possible tornado in Phelps on Monday
• Photos: A blaze at Cairo telecommunications building causes service disruptions
• Evacuations ordered after brush fire breaks out in Laguna Beach